AmorChem l.p.

30 articles with AmorChem l.p.

• AmorChem Announces the Composition of Its Scientific Advisory Committee

  3/2/2018

  AmorChem selected these highly qualified individuals because collectively, they offer an enviable array of diversified expertise and experience in lifesciences venture capital investment, drug discovery and pharmaceutical development.

• AmorChem l.p. Release: Company Spins Out Its SEMA 3A Technology Into Semathera, With 1M$ Seed Investment

  1/11/2017

• AmorChem l.p. Spins Out Its Usp15-Deubiquitinylation (Dub) Drug Discovery Platform Into Corbin Therapeutics, With A First 1M$ Seed Investment

  1/9/2017

• AmorChem l.p. Spins Out Its CD36 Technology Into Mperia Therapeutics, With 1M$ Series A Investment

  9/12/2016

• AmorChem l.p. Release: André-Dupont Prize Awarded To Mike Sapieha!

  10/6/2015

• AmorChem l.p. Invests In Projects At The Personalized Cancer Immunotherapy Program

  4/8/2015

• AmorChem l.p., Université Laval And CHU De Québec Collaborate On The Development Of A Treatment For Friedreich’s Ataxia

  8/4/2014

• Roche And AmorChem l.p. Announce Alliance Focused On Myotonic Muscular Dystrophy 1

  7/29/2014

• AmorChem l.p. Invests In A Novel Drug For Atherosclerosis.

  7/23/2014

• AmorChem l.p. Invests In A Diabetic Macular Edema Opportunity

  6/18/2014

• AmorChem l.p. Aims At Two Major Respiratory Diseases With A Single CFTR Strategy

  6/18/2014

• BELLUS Health And AmorChem l.p. Announce A Partnership To Develop Drug Candidates For AL Amyloidosis

  12/19/2013

• AmorChem l.p., Universite Laval And CHU De Quebec Collaborate On The Development Of A Treatment For Endometriosis And Estrogen-Dependent Cancers

  12/19/2013

• AmorChem l.p.'s KNOCK-OUT™ Event: We Have A Champion!

  12/19/2013

• AmorChem l.p. Invests In The Discovery Of A Novel Cholesterol - Lowering Drug Targeting PCSK9

  12/19/2013

• AmorChem l.p. Invests In New DUB Target For Neuro-Inflammation

  12/19/2013

• AmorChem l.p. Invests In A Novel Titanium Porous Compression Screw For Bone Fixation And Puts In Place A Master Agreement With McGill University

  12/19/2013

• AmorChem l.p. Invests In A Novel Drug For Geographic Atrophy

  12/19/2013

• AmorChem l.p. Invests In A Novel Cholesterol - Lowering Biologic Product Targeting PCSK9 And Puts In Place A Master Agreement With Univalor, L.P.

  12/19/2013

• AmorChem l.p. Invests in the Development of a Therapeutic to Treat Myotonic Dystrophy

  9/20/2013